Could This Be The Biggest Biotech Breakthrough Of The Decade? (SPONSORED POST)

Together, they are on a trajectory which will revolutionize healthcare by offering easily accessible, affordable early detection for a potentially massive market share at a very critical time in our healthcare story.

Like the X-ray, invented in 1895 and enriching medical investors with wild implications for clinical practice, CVR’s early stroke detection device is poised to spark changes far beyond the widespread implementation of the device itself. Indeed, the CSS is only the first phase of CVR’s plans to contribute in a very positive way to medical diagnostics.

Cashed-Up, Patented, and Ready to Take the Market by Storm

CVR has invested $23 million in this technology, with early stage clinical trials complete and now headed toward pivotal trials, eyeing the potential for immediate profitability once FDA market clearance is obtained.

This means there’s only a short window of opportunity between market and profitability.

The critical timeframe is now: The release of a preliminary clinical report is pending any day, and then the full clinical report will follow in 4-8 weeks. Once that happens, the next step is FDA submission, and if successful, delivery to the market.

The team has already lined up manufacturing and components, so once the clinical reports are in, and the FDA hurdle is cleared, it’s breakout time.

For biotech in general, 2017 will be the critical breakout year. For CVR Medical’s patented pre-stroke intervention system, it will be the debut of an amazing new technology that promises to capture the lion’s share of a multi-billion-dollar market that could hit out hard at one of the most pressing medical issues of our time.




 

1 2 3 4
View single page >> |

Legal Disclaimer/Disclosure: This piece is an advertorial and has been paid for. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Jimmy Richards 2 years ago Member's comment

I will be taking a closer look at $CRRVF, thanks.

George Lipton 2 years ago Member's comment

This looks very promising. Are there any downsides that people can see about investing in $CRRVF?

David P. Goldsmith 2 years ago Member's comment

I love learning about these hidden gems on TalkMarkets. $CRRVF

IB Trading 2 years ago Member's comment

Good post, thanks for sharing.

Carl Schwartz 2 years ago Member's comment

This sounds potentially (to quote Trump) HUGE!

Gary Tanashian 2 years ago Contributor's comment

Excellent concept. I've seen story stocks on the TSX-V before, and they often remain just stories. Did a little quick research on Bakema and his patents and it looks good. Still, the penny stock aspect begs in-depth personal research IMO.

Carol Klein 2 years ago Member's comment

Yes, though I don't like some of the vague wording here. E.g. "Expecting results any day now" or "demand could be huge." I would have liked to see more concrete numbers. But overall my interest is certainly piqued.

Harry Goldstein 2 years ago Member's comment

Have to agree with you 100% Gary. Would greatly appreciate it if others share what they learn about this company.